Asif, HudaHudaAsifRahaghi, Franck FFranck FRahaghiOhsumi, AkihiroAkihiroOhsumiPhilley, JulieJuliePhilleyEmtiazjoo, AmirAmirEmtiazjooHirama, TakashiTakashiHiramaBaker, Arthur WArthur WBakerCHIN-CHUNG SHUSilveira, FernandaFernandaSilveiraPoulin, VincentVincentPoulinRizzuto, PetePeteRizzutoNagao, MikiMikiNagaoBurgel, Pierre-RégisPierre-RégisBurgelHays, SteveSteveHaysAksamit, TimothyTimothyAksamitKawasaki, TakeshiTakeshiKawasakiDela Cruz, CharlesCharlesDela CruzAliberti, StefanoStefanoAlibertiNakajima, TakahiroTakahiroNakajimaRuoss, StephenStephenRuossMarras, Theodore KTheodore KMarrasSnell, Gregory IGregory ISnellWinthrop, KevinKevinWinthropMirsaeidi, MehdiMehdiMirsaeidi2023-10-202023-10-202023-032312-0541https://pubmed.ncbi.nlm.nih.gov/37009016/https://scholars.lib.ntu.edu.tw/handle/123456789/636412Nontuberculous mycobacterial (NTM) diseases are difficult-to-treat infections, especially in lung transplant (LTx) candidates. Currently, there is a paucity of recommendations on the management of NTM infections in LTx, focusing on Mycobacterium avium complex (MAC), M. abscessus and M. kansasii.en[SDGs]SDG3journal article10.1183/23120541.00377-2022370090162-s2.0-85152678730https://api.elsevier.com/content/abstract/scopus_id/85152678730